Glioblastoma Metabolism: Insights and Therapeutic Strategies.
Chloé BernhardDamien ReitaSophie MartinNatacha Entz-WerléMonique DontenwillPublished in: International journal of molecular sciences (2023)
Tumor metabolism is emerging as a potential target for cancer therapies. This new approach holds particular promise for the treatment of glioblastoma, a highly lethal brain tumor that is resistant to conventional treatments, for which improving therapeutic strategies is a major challenge. The presence of glioma stem cells is a critical factor in therapy resistance, thus making it essential to eliminate these cells for the long-term survival of cancer patients. Recent advancements in our understanding of cancer metabolism have shown that glioblastoma metabolism is highly heterogeneous, and that cancer stem cells exhibit specific metabolic traits that support their unique functionality. The objective of this review is to examine the metabolic changes in glioblastoma and investigate the role of specific metabolic processes in tumorigenesis, as well as associated therapeutic approaches, with a particular focus on glioma stem cell populations.
Keyphrases
- stem cells
- papillary thyroid
- cancer stem cells
- squamous cell
- induced apoptosis
- cell therapy
- squamous cell carcinoma
- genome wide
- gene expression
- lymph node metastasis
- childhood cancer
- combination therapy
- mesenchymal stem cells
- dna methylation
- cell cycle arrest
- replacement therapy
- cell proliferation
- young adults
- pi k akt
- genetic diversity
- endoplasmic reticulum stress